GENB
Generate Biomedicines, Inc. Common Stock
NASDAQ: GENB · HEALTHCARE · BIOTECHNOLOGY
$12.63
+2.02% today
Updated 2026-04-30
Market cap
$1.59B
P/E ratio
—
P/S ratio
49.75x
EPS (TTM)
$-2.18
Dividend yield
—
52W range
$11 – $16
Volume
0.6M
Generate Biomedicines, Inc. Common Stock (GENB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2024 | 2025 |
|---|---|---|
| Operating cash flow | $-117.75M | $-200.62M |
| Capital expenditures | $3.45M | $3.51M |
| Depreciation | — | — |
| Stock-based comp | $19.46M | $20.58M |
| Free cash flow | $-121.20M | $-204.13M |
| Investing cash flow | — | — |
| Financing cash flow | — | — |
| Dividends paid | — | — |
| Share repurchases | — | — |
| Debt repayment | — | — |
| Net change in cash | — | — |